Inventor · disambiguated record
Jaime Masferrer
Also filed as: MASFERRER JAIME · MASFERRER JAIME L
14 granted patents·24 pending applications·860 citations·filing 1988–2017
95Inventor score
Top patents by PatentIndex Score
38 records- 0197US5380738A2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agentsMONSANTO CO·Filed 1993·Granted Jan 10, 1995·241 cites·21 claims
- 0296US5972986AMethod of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasiaSEARLE & CO·Filed 1997·Granted Oct 26, 1999·168 cites·15 claims
- 0394US6916800B2Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agentPFIZER·Filed 2004·Granted Jul 12, 2005·53 cites·14 claims
- 0492US6469040B2Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasiaSEARLE & CO·Filed 2001·Granted Oct 22, 2002·37 cites·12 claims
- 0591US6858598B1Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasiaSEARLE & CO·Filed 1999·Granted Feb 22, 2005·97 cites·24 claims
- 0686US6833373B1Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasiaSEARLE & CO·Filed 1999·Granted Dec 21, 2004·64 cites·3 claims
- 0780US6025353AMethod of using cyclooxygenase-2 inhibitors as anti-angiogenic agentsSEARLE & CO·Filed 1997·Granted Feb 15, 2000·77 cites·22 claims
- 0876US5719163ASubstituted oxazolyl compounds for the treatment of inflammationSEARLE & CO·Filed 1994·Granted Feb 17, 1998·28 cites·41 claims
- 0976US4906467ANovel, long-duration treatment for glaucomaNEW YORK MEDICAL COLLEGE·Filed 1988·Granted Mar 6, 1990·49 cites·11 claims
- 1072US6689787B1Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasiaSEARLE & CO·Filed 1999·Granted Feb 10, 2004·33 cites·15 claims
- 1170US7772269B2Pyrazole analogsPFIZER·Filed 2007·Granted Aug 10, 2010·2 cites·13 claims
- 1261US2004234624A1Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasiaFiled 2004·Application pending·0 cites
- 1360US2006105961A1Method of using a cox-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasiaPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 1459US2003220384A1Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasiaSEARLE & CO·Filed 2002·Application pending·0 cites
- 1557US7320996B2Indolinone protein kinase inhibitors and cyclooxygenase inhibitors for use in combination therapy for the treatment of cancerSUGEN INC·Filed 2002·Granted Jan 22, 2008·1 cites·2 claims
- 1657US2005187172A1Combination of a Cox-2 inhibitor and a DNA topoisomerase I inhibitor for treatment of neoplasiaFiled 2004·Application pending·0 cites
- 1757US2005227929A1Combination therapy comprising a Cox-2 inhibitor and an antineoplastic agentMASFERRER JAIME L·Filed 2004·Application pending·0 cites
- 1856US2005085477A1Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin-modulating agent for the treatment of neoplasiaPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 1955US6649645B1Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasiaPHARMACIA CORP·Filed 1999·Granted Nov 18, 2003·10 cites·23 claims
- 2055US2005037090A1Combination therapy including a cyclooxygenase-2 inhibitor and an antineoplastic agentFiled 2004·Application pending·0 cites
- 2153US2004127470A1Methods and compositions for the prevention or treatment of neoplasia comprising a Cox-2 inhibitor in combination with an epidermal growth factor receptor antagonistPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 2253US2004053934A1Combination therapy of radiation and a COX-2 inhibitor for the treatment of neoplasiaFiled 2003·Application pending·0 cites
- 2353US2004053935A1Combination therapy of radiation and a COX-2 inhibitor for the treatment of neoplasiaFiled 2003·Application pending·0 cites
- 2452US2004198781A1Carbonic anhydrase inhibitorPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 2551US2006252766A1Methods using a combination of 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasiaPFIZER·Filed 2003·Application pending·0 cites
- 2651US2003220376A1Methods for treating carbonic anhydrase mediated disordersPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 2751US2004067992A1Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasiaPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 2851US2004127539A1Antiangiogenic combination therapy for the treatment of cancerPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 2949US2003225150A1Method of using a COX-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasiaPHARMACIA CORP·Filed 2002·Application pending·0 cites
- 3048US2004121961A1Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancerFiled 2002·Application pending·0 cites
- 3148US2003100594A1Carbonic anhydrase inhibitorPHARMACIA CORP·Filed 2002·Application pending·0 cites
- 3247US11357777B2Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)CYCLERION THERAPEUTICS INC·Filed 2017·Granted Jun 14, 2022·0 cites·23 claims
- 3344US2002103141A1Antiangiogenic combination therapy for the treatment of cancerFiled 2001·Application pending·0 cites
- 3444US2004053900A1Method of using a COX-2 inhibitor and an aromatase inhibitor as a combination therapyPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 3542US2004072889A1Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasiaPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 3641US2003013739A1Methods of using a combination of cyclooxygenase-2 selective inhibitors and thalidomide for the treatment of neoplasiaPHARMACIA CORP·Filed 2002·Application pending·0 cites
- 3740US2003119895A1Methods using a combination of a 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasiaPHARMACIA CORP·Filed 2002·Application pending·0 cites
- 3840US2004122011A1Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapyPHARMACIA CORP·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →